Published in Bacteriol Rev on March 01, 1971
Test for enterotoxigenic Escherichia coli using Y-1 adrenal cells in miniculture. Infect Immun (1975) 13.58
Comparison of the tissue receptors for Vibrio cholerae and Escherichia coli enterotoxins by means of gangliosides and natural cholera toxoid. Infect Immun (1973) 6.58
Polymyxin B-Induced Release of Low-Molecular-Weight, Heat-Labile Enterotoxin from Escherichia coli. Infect Immun (1974) 4.79
Stimulation of steroidogenesis in tissue culture by enterotoxigenic Escherichia coli and its neutralization by specific antiserum. Infect Immun (1974) 4.19
Effects of temperature and salinity on Vibrio cholerae growth. Appl Environ Microbiol (1982) 4.19
Epidermal growth factor: receptors in human fibroblasts and modulation of action by cholera toxin. Proc Natl Acad Sci U S A (1973) 3.44
Interaction of cholera toxin and toxin derivatives with lymphocytes. I. Binding properties and interference with lectin-induced cellular stimulation. J Exp Med (1974) 2.42
Experimental studies on cholera immunization. II. Evidence for protective antitoxic immunity mediated by serum antibodies as well as local antibodies. Infect Immun (1972) 2.37
Interaction of cholera toxin and membrane GM1 ganglioside of small intestine. Proc Natl Acad Sci U S A (1975) 2.18
Hemolytic plaque formation by leukocytes in vitro. Control by vasoactive hormones. J Clin Invest (1974) 1.98
Effects of cholera toxin on in vitro models of immediate and delayed hypersensitivity. Further evidence for the role of cyclic adenosine 3',5'-monophosphate. J Clin Invest (1973) 1.94
Self-transfer and genetic recombination mediated by P, the sex factor of Vibrio cholerae. J Bacteriol (1972) 1.90
Effects of prostaglandins and cholera enterotoxin on intestinal mucosal cyclic AMP accumulation. Evidence against an essential role for prostaglandins in the action of toxin. J Clin Invest (1974) 1.89
Antitoxic immunity in experimental cholera: protection, and serum and local antibody responses in rabbits after enteral and parenteral immunization. Infect Immun (1975) 1.82
Development of a purified cholera toxoid. I. Purification of toxin. Infect Immun (1974) 1.72
Localization of the action of cholera toxin on adenyl cyclase in mucosal epithelial cells of rabbit intestine. J Clin Invest (1972) 1.46
Cholera toxin and cell growth: role of membrane gangliosides. Proc Natl Acad Sci U S A (1974) 1.46
Response of mouse intestinal loop to botulinum C2 toxin: enterotoxic activity induced by cooperation of nonlinked protein components. Infect Immun (1983) 1.41
Pathophysiological effects of Vibrio cholerae and enterotoxigenic Escherichia coli and their exotoxins on eucaryotic cells. Microbiol Rev (1978) 1.39
Vascular permeability factor of Pseudomonas aeruginosa. Infect Immun (1972) 1.36
Interaction of cultured mammalian cells with [125I] diphtheria toxin. Infect Immun (1975) 1.34
Action of Escherichia coli enterotoxin: adenylate cyclase behavior of intestinal epithelial cells in culture. Infect Immun (1974) 1.24
Intestinal myoelectric activity in response to live Vibrio cholerae and cholera enterotoxin. J Clin Invest (1976) 1.22
Experimental edema disease of swine (E. coli enterotoxemia). I. Dectection and preparation of an active principle. Can J Comp Med (1974) 1.20
Fluid and electrolyte transport in rhesus monkeys challenged intracecally with Shigella flexneri 2a. Infect Immun (1976) 1.16
Cholera toxin mimics melanocyte stimulating hormone in inducing differentiation in melanoma cells. Proc Natl Acad Sci U S A (1974) 1.15
Effects of cycloheximide on the response of intestinal mucosa to cholera enterotoxin. J Clin Invest (1973) 1.14
Sequence of events mediating the effect of cholera toxin on rat thymocytes. J Clin Invest (1974) 1.07
Adenosine 3',5'-cyclic monophosphate in Vibrio cholerae. Infect Immun (1975) 1.05
Intestinal secretion induced by vasoactive intestinal polypeptide. A comparison with cholera toxin in the canine jejunum in vivo. J Clin Invest (1978) 1.05
Properties of adenyl cyclase from human jejunal mucosa during naturally acquired cholera and convalescence. J Clin Invest (1972) 1.01
The role of cAMP regulation in controlling inflammation. Clin Exp Immunol (1995) 1.00
Specific binding of cholera toxin to isolated intestinal microvillous membranes. Proc Natl Acad Sci U S A (1974) 0.99
A study of intercellular spaces in the rabbit jejunum during acute volume expansion and after treatment with cholera toxin. J Clin Invest (1974) 0.97
Effect of heat stable and heat labile Escherichia coli enterotoxins and cholera toxin in combination with theophylline on unidirectional sodium and chloride flux in the small intestine of weanling swine. Can J Comp Med (1978) 0.78
Conjugated Linoleic Acid Reduces Cholera Toxin Production In Vitro and In Vivo by Inhibiting Vibrio cholerae ToxT Activity. Antimicrob Agents Chemother (2015) 0.77
Interaction of cholera enterotoxin with cultured adrenal tumor cells. Infect Immun (1975) 0.76
Infectious diseases: annual review of significant publications. Postgrad Med J (1972) 0.75
Role for macrophages and thymus-derived lymphocytes in cholera toxin-induced immunosuppression. Infect Immun (1978) 0.75
Stimulation of epinephrine-sensitive fat cell adenylate cyclase by cytosol: effect of cholera toxin. Proc Natl Acad Sci U S A (1975) 0.75
The Jeremiah Metzger Lecture. Myths, mandarins and molecules: the cautionary tale of cholera. Trans Am Clin Climatol Assoc (1981) 0.75
Proceedings: Cyclic AMP in HeLa cells stimulated with cholera enterotoxin and methylxanthines. Br J Pharmacol (1975) 0.75
Selective inhibition of cholera toxin- and catecholamine-stimulated lipolysis by blocking agents. Infect Immun (1975) 0.75
Purification of tritium-labeled cholera toxin. Infect Immun (1978) 0.75
Failure of cholera enterotoxin to alter cyclic 3',5'-adenosine monophosphate-mediated responses in toad urinary bladder. Infect Immun (1972) 0.75
Comparison of the rate of absorption and proteolysis of [14C]choleragen and [14C]bovine serum albumin in the rat jejunum. Infect Immun (1975) 0.75
A permeability factor (toxin) found in cholera stools and culture filtrates and its neutralization by convalescent cholera sera. Nature (1965) 16.86
An experimental study of the mechanism of action of Vibriod cholerae on the intestinal mucous membrane. J Pathol Bacteriol (1953) 11.72
Experimental cholera in infant rabbits: a method for chemotherapeutic investigation. Br J Pharmacol Chemother (1955) 10.00
Pathogenesis of experimental cholera: biologic ativities of purified procholeragen A. J Immunol (1966) 9.39
Pathogenesis of experimental cholera. Preparation and isolation of choleragen and choleragenoid. J Exp Med (1969) 8.91
The titration of cholera toxin and antitoxin in the rabbit ileal loop. J Infect Dis (1966) 7.43
A heat-labile enterotoxin from strains of Eschericha coli enteropathogenic for pigs. J Infect Dis (1969) 7.19
Studies on Escherichia coli enterotoxin. J Pathol Bacteriol (1967) 7.01
Preparation of the vascular permeability factor of Vibrio cholerae. J Bacteriol (1966) 5.26
An investigation of traveller's diarrhoea. Lancet (1970) 4.99
The nature of the gastrointestinal lesion in asiatic cholera and its relation to pathogenesis: a biopsy study. Am J Trop Med Hyg (1960) 4.45
Response of the rabbit ileal loop to cell-free products from Escherichia coli enteropathogenic for swine. J Infect Dis (1970) 4.18
Ileal loop fluid accumulation and production of diarrhea in rabbits by cell-free products of Clostridium perfringens. J Bacteriol (1969) 3.98
Site and characteristics of electrolyte loss and effect of intraluminal glucose in experimental canine cholera. J Clin Invest (1968) 3.72
Enterotoxicity of bacteria-free culture-filtrate of Vibrio cholerae. Nature (1959) 3.60
Decrease in net stool output in cholera during intestinal perfusion with glucose-containing solutions. N Engl J Med (1968) 3.57
Elevated concentration of adenosine 3':5'-cyclic monophosphate in intestinal mucosa after treatment with cholera toxin. Proc Natl Acad Sci U S A (1970) 3.41
Cholera toxins: purification and preliminary characterization of ileal loop reactive type 2 toxin. J Bacteriol (1968) 3.21
Intestinal fluid and electrolyte transport in human cholera. J Clin Invest (1970) 3.09
Production of highly purified choleragen and choleragenoid. J Infect Dis (1970) 3.05
Factors influencing in vitro skin permeability factor production by Vibrio cholerae. J Bacteriol (1969) 2.99
Cholera toxins. Annu Rev Microbiol (1968) 2.83
Production of Biologically Active Substances by Two Strains of Vibrio cholerae. Infect Immun (1970) 2.71
Enteropathogenic Escherichia coli associated with diarrhea in children and adults. Jpn J Med Sci Biol (1967) 2.62
Effect of intragastric glucose-electrolyte infusion upon water and electrolyte balance in Asiatic cholera. Gastroenterology (1968) 2.51
Stimulation of glycerol production in fat cells by cholera toxin. Nature (1970) 2.34
Endotoxins. Annu Rev Microbiol (1951) 2.29
Serological evidence for the identity of the vascular permeability factor and ileal loop toxin of Vibrio cholerae. J Infect Dis (1970) 2.29
Experimental cholera in humans. Br Med J (1966) 2.26
Small bowel morphology in experimental canine cholera. A light and electron microscopic study. Lab Invest (1970) 2.12
Antitoxic immunity in experimental cholera: observations with purified antigens and the ligated ileal loop model. Infect Immun (1970) 2.01
Effects of vasopressin, theophylline and cyclic adenosine monophosphate on short-circuit current across isolated rabbit ileal mucosa. Nature (1968) 2.00
Experimental cholera. A canine model. Lancet (1966) 1.88
Biochemistry of Vibrio cholerae Virulence I. Purification and Biochemical Properties of PF/Cholera Enterotoxin. Infect Immun (1970) 1.87
Excretion of toxin with stools of cholera patients. J Infect Dis (1961) 1.75
Experimental canine cholera. II. Production by cell-free culture filtrates of Vibrio cholerae. J Infect Dis (1969) 1.69
Antitoxic immunity in experimental canine cholera. J Infect Dis (1970) 1.66
Effect of glycine and glucose on sodium and water adsorption in patients with cholera. Gut (1970) 1.59
Inhibition of cholera toxin action in the rabbit by cycloheximide. Gastroenterology (1969) 1.51
Intestinal microflora in Asiatic cholera. II. The small bowel. J Infect Dis (1970) 1.46
Antitoxic immunity in experimental cholera: observations with purified antigens and the rat foot edema model. Infect Immun (1970) 1.45
Observations on the nature of cholera stools. J Indian Med Assoc (1952) 1.39
Separation of type 2 toxins of Vibrio cholerae. Science (1969) 1.35
Effect of cycloheximide on unidirectional sodium fluxes in the jejunum after cholera exotoxin exposure. Gastroenterology (1970) 1.34
Preliminary results of a study of small intestinal water and solute movement in acute and convalescent human cholera. Indian J Med Res (1968) 1.32
Unidirectional sodium flux in small intestine in experimental canine cholera. Am J Med Sci (1969) 1.32
Intestinal transmural electric potential and its response to glucose in acute and convalescent cholera. Gastroenterology (1969) 1.27
The relationship of superior mesenteric artery blood flow to gut electrolyte loss in experimental cholera. J Infect Dis (1969) 1.27
Fatalities due to malaria in the United States, 1966-1969. J Infect Dis (1970) 1.24
Reversal of cholera exotoxin-induced jejunal secretion by cycloheximide. Johns Hopkins Med J (1970) 1.14
Response of canine Thiry-Vella jejunal loops to cholera exotoxin and its modification by ethacrynic acid. J Infect Dis (1969) 1.07
Pathogenesis of experimental cholera: choleragen-induced rat foot edema; a method of screening anticholera drugs. Proc Soc Exp Biol Med (1969) 1.03
Sodium-potassium stimulated adenosine triphosphatase of the small intestine of man: studies in cholera and other diarrheal diseases. J Lab Clin Med (1968) 1.02
The purification and properties of a thyroid-stimulating factor isolated from Clostridium perfringens. J Biol Chem (1967) 0.97
Biochemical effects of cholera enterotoxin: oxidative metabolism in the infant rabbit. Am J Physiol (1970) 0.95
An effect of cholera toxin on small intestine without direct mucosal contact. Johns Hopkins Med J (1968) 0.94
Concentration and purification of cholera exotoxin by absorption on aluminum compound gels. J Infect Dis (1970) 0.91
SOME OBSERVATIONS ON THE PATHOGENESIS OF CHOLERA. Indian J Med Res (1964) 0.87
Diarrhea and accumulation of intestinal fluid in infant rabbits infected with Vibrio cholerae in an isolated jejunal segment. J Infect Dis (1969) 0.86
The appearance of a choleragenic agent in the blood of infant rabbits infected intestinally with Vibrio cholerae, demonstrated by cross-circulation. J Infect Dis (1969) 0.82
Enterotoxic activity in cholera stool. Indian J Med Res (1965) 0.82
Experimental cholera: observations relevant to the toxin-absorption hypothesis. J Infect Dis (1969) 0.82
Differences in the response of rabbit small intestine to heat-labile and heat-stable enterotoxins of Escherichia coli. Infect Immun (1973) 8.47
Quality of hospital care for seriously ill children in less-developed countries. Lancet (2001) 7.08
Cellular kinetics of the intestinal immune response to cholera toxoid in rats. J Exp Med (1975) 5.02
Experimental canine cholera. I. Development of the model. J Infect Dis (1969) 4.02
Stimulation of jejunal secretion by a crude Escherichia coli enterotixin. Gastroenterology (1972) 4.02
Site and characteristics of electrolyte loss and effect of intraluminal glucose in experimental canine cholera. J Clin Invest (1968) 3.72
An enterotoxin produced by noncholera vibrios. Johns Hopkins Med J (1972) 3.54
Misdiagnosis of HIV infection by HIV-1 plasma viral load testing: a case series. Ann Intern Med (1999) 3.37
Cholera in Africa: lessons on transmission and control for Latin America. Lancet (1991) 3.36
M cell transport of Vibrio cholerae from the intestinal lumen into Peyer's patches: a mechanism for antigen sampling and for microbial transepithelial migration. J Infect Dis (1986) 3.32
Effect of cholera enterotoxin on ion transport across isolated ileal mucosa. J Clin Invest (1972) 3.28
Deactivation of cholera toxin by ganglioside. J Infect Dis (1971) 3.16
Intestinal fluid and electrolyte transport in human cholera. J Clin Invest (1970) 3.09
The role of antigen form and function in the primary and secondary intestinal immune responses to cholera toxin and toxoid in rats. J Exp Med (1978) 2.94
Antibiotic therapy of cholera. Bull World Health Organ (1967) 2.73
Response of man to infection with Vibrio cholerae. II. Protection from illness afforded by previous disease and vaccine. J Infect Dis (1974) 2.73
Infection with the human immunodeficiency virus in prisoners: meeting the health care challenge. Am J Med (1993) 2.68
Vibriocidal and agglutinating antibody patterns in cholera patients. J Infect Dis (1966) 2.67
Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA. AIDS (2000) 2.61
Effect of intragastric glucose-electrolyte infusion upon water and electrolyte balance in Asiatic cholera. Gastroenterology (1968) 2.51
Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract. Clin Infect Dis (2001) 2.49
Effects of prostaglandins, theophylline, and cholera exotoxin upon transmucosal water and electrolyte movement in the canine jejunum. Gastroenterology (1971) 2.39
Differential inhibitory effects of cholera toxoids and ganglioside on the enterotoxins of Vibrio cholerae and Escherichia coli. J Exp Med (1973) 2.38
Stimulation of glycerol production in fat cells by cholera toxin. Nature (1970) 2.34
Replacement of water and electrolyte losses in cholera by an oral glucose-electrolyte solution. Ann Intern Med (1969) 2.28
Effect of Escherichia coli on fluid transport across canine small bowel. Mechanism and time-course with enterotoxin and whole bacterial cells. J Clin Invest (1973) 2.25
Acute undifferentiated human diarrhea in the tropics. II. Alterations in intestinal fluid and electrolyte movements. J Clin Invest (1971) 2.22
Protection against experimental cholera by antitoxin. J Infect Dis (1972) 2.21
Immunity to experimental cholera. III. Enhanced duration of protection after sequential parenteral-oral administration of toxoid to dogs. J Infect Dis (1977) 2.13
Small bowel morphology in experimental canine cholera. A light and electron microscopic study. Lab Invest (1970) 2.12
Hierarchical pattern of mucosal candida infections in HIV-seropositive women. Am J Med (1990) 2.11
Letter: Febrile reactions after methicillin. Lancet (1974) 2.09
Factitious HIV syndrome in young women. AIDS Read (2001) 2.03
Hit HIV-1 hard, but only when necessary. Lancet (2000) 1.98
Effects of cholera toxin on in vitro models of immediate and delayed hypersensitivity. Further evidence for the role of cyclic adenosine 3',5'-monophosphate. J Clin Invest (1973) 1.94
Experimental cholera. A canine model. Lancet (1966) 1.88
Is Clostridium difficile endemic in chronic-care facilities? Lancet (1986) 1.88
Rice-powder electrolyte solution as oral-therapy in diarrhoea due to Vibrio cholerae and Escherichia coli. Lancet (1982) 1.87
Oral immunization of dogs with purified cholera toxin, crude cholera toxin, or B subunit: evidence for synergistic protection by antitoxic and antibacterial mechanisms. Infect Immun (1982) 1.87
Induction of a mucosal antitoxin response and its role in immunity to experimental canine cholera. Infect Immun (1978) 1.84
Determinants of the localization, magnitude, and duration of a specific mucosal IgA plasma cell response in enterically immunized rats. J Immunol (1982) 1.81
Can vitamin D deficiency produce an unusual pain syndrome? Arch Intern Med (1991) 1.80
Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons. J Gen Intern Med (1991) 1.80
Cholera and other enterotoxin-related diarrheal diseases. J Infect Dis (1972) 1.79
Impact of rice based oral rehydration solution on stool output and duration of diarrhoea: meta-analysis of 13 clinical trials. BMJ (1992) 1.74
Priming and suppression of the intestinal immune response to cholera toxoid/toxin by parenteral toxoid in rats. J Immunol (1980) 1.73
Immunity to experimental cholera. I. Protective effect of humoral IgG antitoxin demonstrated by passive immunization. J Immunol (1974) 1.73
Pathogenesis of Salmonella-mediated intestinal fluid secretion. Activation of adenylate cyclase and inhibition by indomethacin. Gastroenterology (1975) 1.71
Experimental canine cholera. II. Production by cell-free culture filtrates of Vibrio cholerae. J Infect Dis (1969) 1.69
Rice-based oral rehydration solution decreases the stool volume in acute diarrhoea. Bull World Health Organ (1985) 1.68
Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women. AIDS (2001) 1.68
Successful colonization and immunization of adult rabbits by oral inoculation with Vibrio cholerae O1. Infect Immun (1983) 1.67
Antitoxic immunity in experimental canine cholera. J Infect Dis (1970) 1.66
Water and electrolyte losses due to cholera in infants and small children: a recovery balance study. Pediatrics (1970) 1.64
Controlled comparison of tetracycline and furazolidone in cholera. Br Med J (1968) 1.59
Antibiotic therapy of cholera in children. Bull World Health Organ (1967) 1.58
Toxins of Vibrio cholerae and Escherichia coli stimulate adenyl cyclase in rat fat cells. Nature (1974) 1.58
Optimal antibiotic therapy in cholera. Bull World Health Organ (1968) 1.58
Aspergillosis in four renal transplant recipients. Diagnosis and effective treatment with amphotericin B. Ann Intern Med (1972) 1.58
Stimulation of insulin secretion by infusion of free fatty acids. J Clin Invest (1969) 1.56
Cholera in children. Lancet (1966) 1.56
Oral fluid--a simple weapon against dehydration in diarrhoea: how it works and how to use it. WHO Chron (1977) 1.53
HIV-positive women: reasons they are tested for HIV and their clinical characteristics on entry into the health care system. J Gen Intern Med (1991) 1.52
Role of cholera toxin in enteric colonization by Vibrio cholerae O1 in rabbits. Infect Immun (1985) 1.51
Genetic polymorphism of CYP2D6 and lung cancer risk in African-Americans and Caucasians in Los Angeles County. Carcinogenesis (1997) 1.49
Intestinal antibodies. J Infect Dis (1978) 1.48
Secretory IgA against enterotoxins in breast-milk. Lancet (1976) 1.47
Low airloss hydrotherapy versus standard care for incontinent hospitalized patients. J Am Geriatr Soc (1998) 1.44
The current status of oral therapy in the treatment of acute diarrheal illness. Am J Clin Nutr (1978) 1.43
Hand washing with soap reduces diarrhoea and spread of bacterial pathogens in a Bangladesh village. J Diarrhoeal Dis Res (1996) 1.43
Efficacy of rice-based oral rehydration. Lancet (1996) 1.40
Probable gallbladder infection in convalescent cholera patients. Lancet (1967) 1.39
Stimulation of intestinal secretion in vitro by culture filtrates of Escherichia coli. J Infect Dis (1972) 1.36
Shiga bacillus dysentery associated with marked leukocytosis and erythrocyte fragmentation. Johns Hopkins Med J (1975) 1.34
Preliminary results of a study of small intestinal water and solute movement in acute and convalescent human cholera. Indian J Med Res (1968) 1.32
Stimulation of insulin secretion by long-chain free fatty acids. A direct pancreatic effect. J Clin Invest (1973) 1.30
Challenge of dogs with live enterotoxigenic Escherichia coli and effects of repeated challenges on fluid secretion in jejunal Thiry-Vella loops. J Infect Dis (1976) 1.30
The relationship of superior mesenteric artery blood flow to gut electrolyte loss in experimental cholera. J Infect Dis (1969) 1.27
Cholera enterotoxin--recent investigations yield insights into transport processes. Am J Med (1971) 1.27
Adenyl cyclase in human platelets: activity and responsiveness. Biochem Biophys Res Commun (1969) 1.26
Cancer incidence in women with or at risk for HIV. Int J Cancer (2001) 1.23
Gastric acidity in cholera and noncholera diarrhoea. Bull World Health Organ (1972) 1.23
Hepatitis B in an oncology unit. N Engl J Med (1974) 1.23
Convalescent carriers of Vibrio cholerae. Detection and detailed investigation. Ann Intern Med (1970) 1.23
Hypoglycemia in children with acute diarrhoea. Lancet (1966) 1.22
Cellular dissemination of priming for a mucosal immune response to cholera toxin in rats. J Immunol (1981) 1.22
More pathogenic vibrios. N Engl J Med (1979) 1.22
Antitoxic immunity to cholera in dogs immunized orally with cholera toxin. Infect Immun (1980) 1.21
Antitoxic immunity in experimental canine cholera. Trans Assoc Am Physicians (1968) 1.20
Determinants of the immunogenicity of live virulent and mutant Vibrio cholerae O1 in rabbit intestine. Infect Immun (1987) 1.20